Carmen M. Labandeira

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

Diego Santos‐García, T. de Deus Fonticoba, E. Suárez Castro et al. · Parkinsonism & Related Disorders · 2019 · 128 citations

Quality Of Life, Health Sciences, Psychiatry +14

Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19

Ana I. Rodríguez‐Pérez, Carmen M. Labandeira, María A. Pedrosa et al. · Journal of Autoimmunity · 2021 · 91 citations · Full text

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

María A. Pedrosa, Rita Valenzuela, Pablo Garrido‐Gil et al. · Clinical Science · 2021 · 65 citations · Full text

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

Carmen M. Labandeira, María A. Pedrosa, Aloia Quijano et al. · npj Parkinson s Disease · 2022 · 44 citations · Full text

Rho kinase inhibitor fasudil reduces <scp>l</scp>‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease

Andrea López-López, Carmen M. Labandeira, José L. Labandeira‐García et al. · British Journal of Pharmacology · 2020 · 37 citations · Full text